Northwest Biotherapeutics (NWBO)
OTHER OTC:NWBO
Holding NWBO?
Track your performance easily

Northwest Biotherapeutics (NWBO) Financial Statements

405 Followers

Northwest Biotherapeutics Financial Overview

Northwest Biotherapeutics's market cap is currently ―. The company's EPS TTM is $-0.064; its P/E ratio is -4.78; Northwest Biotherapeutics is scheduled to report earnings on May 16, 2018, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 510.00K$ 284.00K$ 445.00K$ 406.00K$ 201.00K
Gross Profit$ 510.00K$ 284.00K$ 445.00K$ 406.00K$ 201.00K
EBIT$ -16.17M$ -18.46M$ -17.68M$ -16.91M$ -13.15M
EBITDA$ -15.16M$ -17.38M$ -17.46M$ -16.42M$ -12.66M
Net Income Common Stockholders$ -18.31M$ -18.88M$ -19.26M$ -19.10M$ -13.93M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 2.88M$ 2.48M$ 2.13M$ 6.10M$ 1.42M
Total Assets$ 28.23M$ 28.57M$ 27.86M$ 31.49M$ 28.44M
Total Debt$ 37.81M$ 32.58M$ 32.79M$ 27.19M$ 30.76M
Net Debt$ 34.93M$ 30.10M$ 30.66M$ 21.09M$ 29.33M
Total Liabilities$ 85.97M$ 82.04M$ 74.92M$ 68.94M$ 89.47M
Stockholders Equity$ -76.50M$ -73.28M$ -65.77M$ -65.12M$ -61.03M
Cash Flow-
Free Cash Flow$ -16.72M$ -12.64M$ -17.38M$ -14.36M$ -12.77M
Operating Cash Flow$ -16.20M$ -12.41M$ -16.96M$ -13.92M$ -11.52M
Investing Cash Flow$ -521.00K$ -239.00K$ -418.00K$ -437.00K$ -1.25M
Financing Cash Flow$ 17.14M$ 12.09M$ 14.41M$ 17.12M$ 8.64M
Currency in USD

Northwest Biotherapeutics Earnings and Revenue History

Northwest Biotherapeutics Debt to Assets

Northwest Biotherapeutics Cash Flow

Northwest Biotherapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis